Skip to main content

Advertisement

Open Peer Review Reports for: HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
12 Mar 2009 Submitted Original manuscript
1 May 2009 Reviewed Reviewer Report - A Serrano-Olvera
10 May 2009 Reviewed Reviewer Report - Adelaida Garcia-Velasco
10 May 2009 Reviewed Reviewer Report - Karina Dahl Steffensen
11 Jul 2009 Author responded Author comments - Jessica N. McAlpine
Resubmission - Version 2
11 Jul 2009 Submitted Manuscript version 2
3 Aug 2009 Reviewed Reviewer Report - Adelaida Garcia-Velasco
12 Aug 2009 Reviewed Reviewer Report - Karina Dahl Steffensen
Resubmission - Version 3
Submitted Manuscript version 3
1 Oct 2009 Author responded Author comments - Jessica N. McAlpine
Resubmission - Version 4
1 Oct 2009 Submitted Manuscript version 4
4 Nov 2009 Author responded Author comments - Jessica N. McAlpine
Resubmission - Version 5
4 Nov 2009 Submitted Manuscript version 5
1 Dec 2009 Author responded Author comments - Jessica N. McAlpine
Resubmission - Version 6
1 Dec 2009 Submitted Manuscript version 6
Publishing
10 Dec 2009 Editorially accepted
10 Dec 2009 Article published 10.1186/1471-2407-9-433

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement